P
Pascale Barberger-Gateau
Researcher at French Institute of Health and Medical Research
Publications - 118
Citations - 14445
Pascale Barberger-Gateau is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Dementia & Activities of daily living. The author has an hindex of 46, co-authored 118 publications receiving 13202 citations. Previous affiliations of Pascale Barberger-Gateau include Centre national de la recherche scientifique & University of Bordeaux.
Papers
More filters
Journal ArticleDOI
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Bruno Dubois,Howard Feldman,Claudia Jacova,Steven T. DeKosky,Pascale Barberger-Gateau,Jeffrey L. Cummings,André Delacourte,Douglas Galasko,Serge Gauthier,Gregory A. Jicha,Kenichi Meguro,John T. O'Brien,Florence Pasquier,Philippe Robert,Martin N. Rossor,Steven Salloway,Yaakov Stern,Pieter Jelle Visser,Philip Scheltens +18 more
TL;DR: The NINCDS-ADRDA and DSM-IV-TR criteria for Alzheimer's disease (AD) are the prevailing diagnostic standards in research; however, they have now fallen behind the unprecedented growth of scientific knowledge as discussed by the authors.
Journal ArticleDOI
Revising the definition of Alzheimer's disease: a new lexicon.
Bruno Dubois,Howard Feldman,Howard Feldman,Howard Feldman,Claudia Jacova,Jeffrey L. Cummings,Steven T. DeKosky,Pascale Barberger-Gateau,André Delacourte,Giovanni B. Frisoni,Nick C. Fox,Douglas Galasko,Serge Gauthier,Harald Hampel,Gregory A. Jicha,Kenichi Meguro,John T. O'Brien,Florence Pasquier,Philippe Robert,Martin N. Rossor,Steven Salloway,Marie Sarazin,Leonardo Cruz de Souza,Yaakov Stern,Pieter Jelle Visser,Pieter Jelle Visser,Philip Scheltens +26 more
TL;DR: This paper aims to advance the scientific discussion by providing broader diagnostic coverage of the AD clinical spectrum and by proposing a common lexicon as a point of reference for the clinical and research communities.
Journal ArticleDOI
Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms
Hélène Amieva,Mélanie Le Goff,Xavier Millet,Jean Marc Orgogozo,Karine Pérès,Pascale Barberger-Gateau,Hélène Jacqmin-Gadda,Jean-François Dartigues +7 more
TL;DR: The emergence of the first clinical symptoms over a 14‐year period of follow-up before the dementia phase of AD is examined.
Journal ArticleDOI
Intake of flavonoids and risk of dementia
Daniel Commenges,V Scotet,S Renaud,Hélène Jacqmin-Gadda,Pascale Barberger-Gateau,Jean-François Dartigues +5 more
TL;DR: The intake of antioxidant flavonoids is inversely related to the risk of incident dementia, and is associated with a lower incidence of dementia in a cohort of 1367 subjects above 65 years of age.
Journal ArticleDOI
Brain fuel metabolism, aging, and Alzheimer’s disease
Stephen C. Cunnane,Scott Nugent,Maggie Roy,Alexandre Courchesne-Loyer,Etienne Croteau,Sébastien Tremblay,Alex Castellano,Fabien Pifferi,Christian Bocti,Nancy Paquet,Hadi Begdouri,M'hamed Bentourkia,Eric Turcotte,Michèle Allard,Pascale Barberger-Gateau,Tamas Fulop,Stanley I. Rapoport +16 more
TL;DR: It is suggested that brain hypometabolism may precede and therefore contribute to the neuropathologic cascade leading to cognitive decline in AD, and strategies to reduce the risk of AD should aim to improve insulin sensitivity by improving systemic glucose utilization, or bypass deteriorating brain glucose metabolism using approaches that safely induce mild, sustainable ketonemia.